Trefoil peptides and surgical disease

British Journal of Surgery

Volumn 86, Issue 6, 1999, Pages 740-748

  Longman, R J ^a   Thomas, M G ^a   Poulsom, R ^b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; MUCIN; TREFOIL PEPTIDE;

ARTICLE; BREAST CANCER; CARCINOMA; CELL MIGRATION; DATA BASE; DIGESTIVE SYSTEM INFLAMMATION; EPITHELIUM; EPITHELIUM CELL; GASTROINTESTINAL MUCOSA; HEALING; HUMAN; HUMAN TISSUE; MEDICAL INFORMATION; NEOPLASM; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

EID: 0033013904     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1999.01131.x     Document Type: Article

References (69)

1. 1 Thim L. A new family of growth factor-like peptides. 'Trefoil' disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 1989; 250: 85-90.
2. 2 Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cell line. Nucleic Acids Res 1982; 24: 7895-903.
3. 3 Jorgensen KH, Thim L, Jacobsen HE. Pancreatic spasmolytic polypeptide (PSP): 1. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul Pept 1982; 3: 207-19.
4. 4 Suemori S, Lynch-Devaney K, Podolsky DK. Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci U S A 1991; 88: 11017-21.
5. 5 Schmitt H, Wundrack I, Beck S, Gott P, Welter C, Shizuya H et al. A third P-domain peptide gene (TFF3), human intestinal trefoil factor, maps to 21q22.3. Cytogenet Cell Genet 1996; 72: 299-302.
6. 6 Seib T, Blin T, Hilgert K, Scifert M, Theisinger B, Engel M et al. The three human trefoil genes TFF1, TFF2, and TFF3 are located within a region of 55 kb on chromosome 21q22.3. Genomics 1997; 40: 200-2.
7. 7 Hoffmann W. A new repetitive protein from Xenopus laevis skin highly homologous to pancreatic, spasmolytic polypeptide. J Biol Chem 1988; 263: 7686-90.
8. 8 Rio MC, Bellocq JP, Daniel JY, Tomasetto C, Lathe R, Chenard MP et al. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 1988; 241: 705-8.
9. 9 Hanby AM, Poulsom R, Singh S, Elia G, Jeffery RE, Wright NA. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 1993; 105: 1110-16.
10. 10 Tomasetto C, Rio M-C, Gautier C, Wolf C, Hareuvani M, Chambon P et al. hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J 1990; 9: 407-14.
11. 11 Hanby AM, Poulsom R, Elia G, Singh S, Longcroft JM, Wright NA. The expression of trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in 'gastric metaplasia' of the proximal duodenum: implications for the nature of 'gastric metaplasia'. J Pathol 1993; 169: 355-60.
12. 12 Podolsky DK, Lynch-Devaney K, Stow JL, Oates P, Murgue B, DeBeaumont M et al. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 1993; 268: 6694-702 and 12230 (Erratum).
13. 13 Playford RJ, Marchbank T, Chinery R, Evison R, Pignatelli M, Boulton RA et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995; 108: 108-16.
14. 14 Taupin DR, Pang KC, Green SP, Giraud AS. The trefoil peptides spasmolytic polypeptide and intestinal trefoil factor are major secretory products of the rat gut. Peptides 1995; 16: 1001-5.
15. 15 Probst JC, Zetzsche T, Weber M, Theilemann P, Skutella T, Landgraf R et al. Human intestinal trefoil factor is expressed in human hypothalamus and pituitary: evidence for a novel neuropeptide. FASEB J 1996; 10: 1518-23.
16. 16 Offner GD, Nunes DP, Troxler RF, Oppenheim FG. Identification of the trefoil protein pS2 in human salivary glands. J Dent Res 1997; 76: 1154 (Abstract).
17. 17 Hauser F, Poulsom R, Chinery R, Rogers LA, Hanby AM, Wright NA et al. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci U S A 1993; 90: 6961-5.
18. 18 Piggott NH, Henry JA, May FEB, Westley BR. Antipeptide antibodies against pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry. J Pathol 1991; 163: 95-104.
19. 19 Poulsom R, Hanby AM, Lalani E-N, Hauser F, Hoffman W, Stamp GWH. Intestinal trefoil factor (TFF3) and pS2 (TFF1), but not spasmolytic polypeptide (TFF2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium. J Pathol 1997; 183: 30-8.
20. 20 Wright NA, Poulsom R, Stamp GW, Hall PA, Jeffrey RE, Longcroft JM et al. Epidermal growth factor (EGF/URO) induces expression of regulating peptides in damaged human gastrointestinal tissues. J Pathol 1990; 162: 279-84.
21. 21 Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK. Trefoil peptide protection of intestinal epithelial barrier function: co-operative interaction with mucin glycoprotein. Gastroenterology 1995; 109: 516-23.
22. 22 Engel E, Guth PH, Nishizaki Y, Kaunitz JD. Barrier function of the gastric mucus gel. Am J Physiol 1995; 269: G994-9.
23. 23 Tanaka S, Podolsky DK, Engel E, Guth PH, Kaunitz JD. Human spasmolytic polypeptide decreases proton permeation through gastric mucus in vivo and in vitro. Am J Physiol 1997; 272:G1473-80.
24. 24 Playford RJ, Marchbank T, Goodlad RA, Chinery RA, Poulsom R, Hanby AM. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci U S A 1996; 93: 2137-42.
25. 25 Mckenzie C, Marchbank T, Playford RJ, Otto W, Thim L, Parsons ME. Pancreatic spasmolytic polypeptide protects the gastric mucosa but does not inhibit acid secretion or motility. Am J Physiol 1997; 273: G112-17.
26. 26 Konturek PC, Brzozowski T, Konturek SJ, Elia G, Wright N, Sliwowski Z et al. Role of spasmolytic polypeptide in healing of stress-induced gastric lesions in rats. Regul Pept 1997; 68: 71-9.
27. 27 Babyatsky MW, deBeaumont M, Thim L, Podolsky DK. Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology 1996; 110: 489-97.
28. 28 Mashimo H, Wu D-C, Podolsky DK, Kishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996; 274: 262-5.
29. 29 Chinery R, Cox HM. Immunoprecipitation and characterization of a binding protein specific for the peptide, intestinal trefoil factor. Peptides 1995; 16: 749-55.
30. 30 Tan X-D, Hseuh W, Chang H, Wei K-R, Gonzalez-Crussi F. Characterization of a putative receptor for intestinal trefoil factor in rat small intestine: identification by in situ binding and ligand blotting. Biochem Biophys Res Commun 1997; 237: 673-7.
31. 31 Ogata H, Podolsky DK. Trefoil peptide expression and secretion is regulated by neuropeptides and acetylcholine. Am J Physiol 1997; 273: G348-54.
32. 32 Tran CP, Familiari M, Parker LM, Whitehead RH, Giraud AS. Short-chain fatty acids inhibit intestinal trefoil factor gene expression in colon cancer cells. Am J Physiol 1998; 275: G85-94.
33. 33 May FEB, Westley BR. Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells. Cancer Res 1986; 46: 6034-40.
34. 34 May FEB, Westley BR. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells. J Pathol 1997; 182: 404-13.
35. 35 Cook GA, Yeomans ND, Giraud AS. Temporal expression of trefoil peptides in the TGF-alpha knockout mouse after gastric ulceration. Am J Physiol 1997; 272: G1540-9.
36. 36 Dignass A, Lynch-Devaney C, Kindon H, Thim L, Podolsky DK. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 1994; 94: 376-83.
37. 37 Liu D, el-Hariry I, Karayiannakis AJ, Wilding J, Chinery R, Kmiot W et al. Phosphorylation of β-catenin and epidermal growth factor receptor by intestinal trefoil factor. Lab Invest 1997; 77: 557-63.
38. 38 Efstathiou JA, Noda M, Rowan A, Dixon C, Chinery R, Jawhari A et al. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc Natl Acad Sci U S A 1998; 95: 3122-7.
39. 39 Kanai M, Mullen C, Podolsky DK. Intestinal trefoil factor induces activation of extracellular signal-regulated protein kinase in intestinal epithelial cells. Proc Natl Acad Sci U S A 1998; 95: 178-82.
40. 40 Williams R, Stamp GW, Gilbert C, Pignatelli M, Lalani EN. pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3-D collagen gel. J Cell Sci 1996; 109: 63-71.
41. 41 Theisinger B, Welter C, Seitz G, Rio M-C, Lathe R, Chambon P et al. Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma. Eur J Cancer 1991; 27: 770-3.
42. 42 Seitz G, Theisinger B, Tomasetto C, Rio M-C, Chambon P, Blin N et al. Breast cancer-associated protein pS2 expression in tumors of the biliary tract. Am J Gastroenterol 1991; 86: 1491-4.
43. 43 Hanby AM, Poulsom R, Singh S, Jankowski J, Hopwood D, Elia G et al. Hyperplastic polyps: a cell lineage which both synthesizes and secretes trefoil-peptides and has phenotypic similarity with the ulcer-associated cell lineage. Am J Pathol 1993; 142: 663-8.
44. 44 Singh S, Poulsom R, Hanby AM, Rogers LA, Wright NA, Sheppard MC et al. Expression of oestrogen receptor and oestrogen-inducible genes pS2 and ERD5 in large bowel mucosa and cancer. J Pathol 1998; 184: 153-60.
45. 45 Henry JA, Bennett MK, Piggott NH, Levett DL, May FEB, Westley BR. Expression of the pNR-1/pS2 protein in diverse human epithelial tumours. Br J Cancer 1991; 64: 677-82.
46. 46 Taupin D, Ooi K, Yeomans N, Giraud A. Conserved expression of intestinal trefoil factor in the human colonic adenoma-carcinoma sequence. Lab Invest 1996; 75: 25-32.
47. 47 Uchino H, Kataoka H, Itoh H, Koono M. Expression of intestinal trefoil factor mRNA is downregulated during progression of colorectal carcinomas. J Clin Pathol 1997; 50: 932-4.
48. 48 Welter C, Theisinger B, Seitz G, Tomasetto C, Rio M-C, Chambon P et al. Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Lab Invest 1992; 66: 187-92.
49. 49 Henry JA, Piggott NH, Mallick UK, Nicholson S, Farndon JR, Westley BR et al. PNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br J Cancer 1991; 63: 615-22.
50. 50 Theisinger B, Seitz G, Dooley S, Welter C. A second trefoil protein, ITF/hP1.B is transcribed in human breast cancer. Breast Cancer Res Trent 1996; 38: 145-51.
51. 51 Wysocki SJ, Hahnel E, Masters A, Smith V, Mccartney AJ, Hahnel R. Detection of pS2 messenger RNA in gynecological cancers. Cancer Res 1993; 50: 1800-2.
52. 52 Lipponen PK, Eskelinen MJ. Expression of p52 protein in transitional cell bladder tumours. J Pathol 1994; 173: 327-32.
53. 53 Bonkhoff H, Stein U, Welter C, Remberger K. Differential expression of the pS2 protein in the human prostate and prostate cancer: association with premalignant changes and neuroendocrine differentiation. Hum Pathol 1995; 26: 824-8.
54. 54 Luqmani YA, Ryall G, Shousha A, Coombes RC. An immunohistochemical survey of pS2 expression in human epithelial cancers. Int J Cancer 1992; 50: 302-4.
55. 55 Singh S, Poulsom R, Wright NA, Sheppard MC, Langman MJS. Differential expression of oestrogen receptor and oestrogen inducible genes in gastric mucosa and cancer. Gut 1997; 40: 516-20.
56. 56 Singh S, Baker PR, Poulsom R, Wright NA, Sheppard MC, Langman MJS et al. Expression of oestrogen receptor and oestrogen-inducible genes in pancreatic cancer. Br J Surg 1997; 84: 1085-9.
57. 57 Nunez AM, Berry M, Imler JL, Chambon P. The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J 1989; 8: 823-9.
58. 58 Wilson YG, Rhodes M, Ibrahim NBN, Padfield CJH, Cawthorn SJ. Immunocytochemical staining of pS2 protein in fine-needle aspirates from breast cancer is an accurate guide to response to tamoxifen in patients aged over 70 years. Br J Surg 1994; 81: 1155-8.
59. 59 Soubeyran I, Quenel N, Coindre J-M, Bonichon F, Durand M, Wafflart J et al. pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients. Br J Cancer 1996; 74: 1120-5.
60. 60 Foekens JA, Portengen H, Look MP, van Putten WL, Thirion B, Bontenbal M et al. Relationship of pS2 with response to tamoxifen therapy in patients with recurrent breast cancer. Br J Cancer 1994; 70: 1217-23.
61. 61 Rio MC, Bellocq JP, Gairard B, Rasmussen UB, Krust A, Koehl C et al. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci U S A 1987; 84: 9243-7.
62. 62 Lefebvre O, Chenard M-P, Masson R, Linares J, Dierich A, LeMeur M et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996; 274: 259-62.
63. 63 Otto WR, Rao J, Cox HM, Kotzian E, Lee CY, Goodlad RA et al. Effects of pancreatic spasmolytic polypeptide (PSP) on epithelial cell function. Eur J Biochem 1996; 235: 64-72.
64. 64 Wright NA, Elia G, Pike C. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in gastrointestinal stem cells. Nature 1990; 343: 82-5.
65. 65 Wright NA. Migration of the ductular elements of gut-associated glands gives clues to the histogenesis of structures associated with responses to acid hypersecretory state: the origins of 'gastric metaplasia' in the duodenum, of the specialized mucosa of Barrett's esophagus and of pseudopyloric metaplasia. Yale J Biol Med 1996; 69: 147-53.
66. 66 Podolsky DK. Healing the epithelium: solving the problem from two sides. J Gastroenterol 1997; 32: 122-6.
67. 67 Hanby AM, Pera M, Filipe I, Duranceau A, Wright NA, Pera M et al. Duodenal content reflux esophagitis in the rat: an animal model for the ulcer-associated cell lineage (UACL)? Am J Pathol 1997; 151: 1819-24.
68. 68 Poulsom R, Begos DE, Modlin IM. Molecular aspects of restitution: functions of trefoil peptides. Yale J Biol Med 1996; 69: 137-46.
69. 69 Duclos B, Rio MC, Reimund JM, Chamouard P, Baumann R, Chambon P et al. Increased pS2 secretion in serum of Crohn's disease (CD) patients. Gastroenterology 1991; 100(Suppl): A520 (Abstract).